-
-
LIFYORLI
- QTY 9
- 150 MG/DAY
- Capsule
- Near 77381
RELACORILANT (REL a KOR i lant) treats ovarian cancer. It works by blocking a hormone in the body that can help cancer cells survive. This helps chemotherapy work better, so it can slow or stop the spread of cancer cells.
Change Location
Set Price Drop Alert for:
LIFYORLI
- QTY 9
- 150 MG/DAY
- Capsule
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
LIFYORLI
- QTY 9
- 150 MG/DAY
- Capsule
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
LIFYORLI Lifestyle Interactions
-
Relacorilant 100mg, Oral capsule
• Interaction: Cannabis• Severity: Major• Notes for Consumers: Discuss cannabis use with your care team. The effects of cannabis may be altered if used with your medication. Call emergency services right away if you experience slow or shallow breathing, shortness of breath, feeling faint, dizziness, confusion, or trouble staying awake.• Notes for Professionals: Advise patients to avoid cannabis use during relacorilant treatment. Concomitant use may alter the exposure of some cannabinoids and increase the risk for adverse reactions. The cannabinoids delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are CYP3A substrates and relacorilant is a strong CYP3A inhibitor. Concomitant use of a cannabinoid product containing THC and CBD at an approximate 1:1 ratio with another strong CYP3A inhibitor increased THC, 11-OH-THC, and CBD peak exposure by 1.3-, 3-, and 1.9-fold respectively.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
